Cargando…
Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alc...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189699/ https://www.ncbi.nlm.nih.gov/pubmed/25302021 http://dx.doi.org/10.2147/PPA.S57358 |
_version_ | 1782338402632335360 |
---|---|
author | Luquiens, Amandine Aubin, Henri-Jean |
author_facet | Luquiens, Amandine Aubin, Henri-Jean |
author_sort | Luquiens, Amandine |
collection | PubMed |
description | Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alcohol use disorder appears to be the reluctance to engage in abstinence. Risk reduction is a developing approach in the treatment of alcohol use disorders, drawing its inspiration, with quite a delay, from the decades-long dominant approach in other substance use disorders. A paradigm shift has recently occurred that places more of an emphasis on reducing alcohol as a therapeutic strategy for patients with alcohol use disorder, to better meet the patients’ preferences and needs. The development and recent approval of nalmefene, in alcohol-dependent adults with a high drinking risk level, contributes to enlarging the therapeutic arsenal for alcohol dependence, strengthening the legitimacy of alcohol reduction strategies. |
format | Online Article Text |
id | pubmed-4189699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41896992014-10-09 Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene Luquiens, Amandine Aubin, Henri-Jean Patient Prefer Adherence Review Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alcohol use disorder appears to be the reluctance to engage in abstinence. Risk reduction is a developing approach in the treatment of alcohol use disorders, drawing its inspiration, with quite a delay, from the decades-long dominant approach in other substance use disorders. A paradigm shift has recently occurred that places more of an emphasis on reducing alcohol as a therapeutic strategy for patients with alcohol use disorder, to better meet the patients’ preferences and needs. The development and recent approval of nalmefene, in alcohol-dependent adults with a high drinking risk level, contributes to enlarging the therapeutic arsenal for alcohol dependence, strengthening the legitimacy of alcohol reduction strategies. Dove Medical Press 2014-09-29 /pmc/articles/PMC4189699/ /pubmed/25302021 http://dx.doi.org/10.2147/PPA.S57358 Text en © 2014 Luquiens and Aubin. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Luquiens, Amandine Aubin, Henri-Jean Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title | Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title_full | Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title_fullStr | Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title_full_unstemmed | Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title_short | Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
title_sort | patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189699/ https://www.ncbi.nlm.nih.gov/pubmed/25302021 http://dx.doi.org/10.2147/PPA.S57358 |
work_keys_str_mv | AT luquiensamandine patientpreferencesandperspectivesregardingreducingalcoholconsumptionroleofnalmefene AT aubinhenrijean patientpreferencesandperspectivesregardingreducingalcoholconsumptionroleofnalmefene |